We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+13.26%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$232M
AUM Growth
-$69.4M
Cap. Flow
-$146M
Cap. Flow %
-62.7%
Top 10 Hldgs %
36.64%
Holding
63
New
12
Increased
9
Reduced
17
Closed
25

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$8.51M
2
CTLT
CATALENT, INC.
CTLT
+$7.82M
3
BAX icon
Baxter International
BAX
+$7.15M
4
UHS icon
Universal Health Services
UHS
+$6.95M
5
UNH icon
UnitedHealth
UNH
+$6.76M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$35.6M
2
HUM icon
Humana
HUM
+$19.1M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$15.7M
4
SNN icon
Smith & Nephew
SNN
+$11.6M
5
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$9.55M

Sector Composition

Rank Sector Weight
1 Healthcare 98.4%
2 Energy 1.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
1
Abbott
ABT
$187B
$9.79M 4.21%
90,000
+65,000
+260% +$6.59M
DHR icon
2
Danaher
DHR
$144B
$9.69M 4.17%
50,760
-39,480
-44% -$7.02M
JNJ icon
3
Johnson & Johnson
JNJ
$625B
$8.93M 3.84%
60,000
+30,000
+100% +$4.44M
TMO icon
4
Thermo Fisher Scientific
TMO
$220B
$8.83M 3.8%
20,000
-86,069
-81% -$35.6M
HUM icon
5
Humana
HUM
$46.2B
$8.28M 3.56%
20,000
-47,500
-70% -$19.1M
MOH icon
6
Molina Healthcare
MOH
$10.3B
$8.24M 3.54%
45,000
+19,000
+73% +$3.46M
LLY icon
7
Eli Lilly
LLY
$1.06T
$8.14M 3.5%
+55,000
New +$8.51M
CTLT
8
DELISTED
CATALENT, INC.
CTLT
$7.92M 3.41%
+92,500
New +$7.82M
MCK icon
9
McKesson
MCK
$101B
$7.82M 3.36%
52,500
+20,000
+62% +$3.04M
LH icon
10
Labcorp
LH
$25.9B
$7.53M 3.24%
46,560
-23,280
-33% -$3.69M
ZBH icon
11
Zimmer Biomet
ZBH
$18.4B
$7.49M 3.22%
56,650
+30,900
+120% +$4.04M
HCA icon
12
HCA Healthcare
HCA
$89.5B
$7.48M 3.22%
60,000
-45,000
-43% -$5.57M
PPD
13
DELISTED
PPD, Inc. Common Stock
PPD
$7.4M 3.18%
200,000
+50,000
+33% +$1.58M
CNC icon
14
Centene
CNC
$32.5B
$7.29M 3.14%
125,000
-45,000
-26% -$2.8M
MDT icon
15
Medtronic
MDT
$112B
$7.27M 3.13%
70,000
+10,000
+17% +$1M
UHS icon
16
Universal Health Services
UHS
$10.5B
$6.96M 2.99%
+65,000
New +$6.95M
UNH icon
17
UnitedHealth
UNH
$370B
$6.86M 2.95%
+22,000
New +$6.76M
BAX icon
18
Baxter International
BAX
$14.2B
$6.84M 2.94%
+85,000
New +$7.15M
BSX icon
19
Boston Scientific
BSX
$71.5B
$6.5M 2.79%
+170,000
New +$6.55M
SYK icon
20
Stryker
SYK
$130B
$6.25M 2.69%
30,000
-30,000
-50% -$5.83M
COR icon
21
Cencora
COR
$61.2B
$5.82M 2.5%
60,000
+35,000
+140% +$3.48M
DGX icon
22
Quest Diagnostics
DGX
$26.3B
$5.72M 2.46%
50,000
-75,000
-60% -$8.86M
CRL icon
23
Charles River Laboratories
CRL
$12.8B
$5.66M 2.43%
+25,000
New +$5.19M
AVTR icon
24
Avantor
AVTR
$9.19B
$5.62M 2.42%
250,000
+75,000
+43% +$1.56M
REGN icon
25
Regeneron Pharmaceuticals
REGN
$80.8B
$5.6M 2.41%
10,000
-5,000
-33% -$3.03M
1
2 3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q3 2020 Portfolio in Review

As of Q3 2020, Sivik Global Healthcare held 63 positions worth $232M, down 23% from $302M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sivik Global Healthcare withdrew a net $146M in Q3 2020, closing 25 positions and reducing 17 holdings. Its most notable exit was Smith & Nephew, an estimated $11.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 95% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in Eli Lilly worth $8.14M.

  • Sivik Global Healthcare's largest Q3 2020 buy was Eli Lilly: 55,000 shares worth $8.14M.
  • Sivik Global Healthcare added most to Abbott in Q3 2020, an estimated $6.59M increase.
  • Sivik Global Healthcare's biggest Q3 2020 reduction was Thermo Fisher Scientific, cutting an estimated $35.6M.
  • Sivik Global Healthcare fully exited Smith & Nephew in Q3 2020, selling an estimated $11.6M.
  • Sivik Global Healthcare's ten largest holdings make up 37% of its $232M portfolio in Q3 2020.
  • Sivik Global Healthcare opened 12 new positions and closed 25 in Q3 2020.
  • Sivik Global Healthcare's portfolio value fell 23% quarter-over-quarter to $232M.

Based on Sivik Global Healthcare's 13F filing for Q3 2020, filed 13 Nov 2020.